Although treatment of TBI 3xTg-AD mice with the peptide did not result in a significant effect on total tau or P-tau levels, it was able to reduce the toxicity of the brain homogenates after administration to the worms proving its capacity in reducing the proteotoxic tau forms. The gene discussed is MAPT; the disease is Alzheimer disease.